• Contact
Aravax
  • About
    • About Aravax
    • Management
    • Board of Directors
    • Advisors
    • Careers
  • Food Allergies and Our Approach
    • Food Allergies Overview
    • Our Approach and Platform
  • Programmes and Clinical Trials
    • PVX108 for Peanut Allergy
    • Phase 2 Clinical Trials
    • Phase 1 Clinical Trials
  • News & Events
    • News
    • Events
    • In the News
  • Menu Menu

News & Events

Latest News

Aravax presents encouraging preliminary Phase I safety data at the first Gordon Research Conference

13 January 2018/by Admin

Aravax forms Scientific Advisory Board

9 January 2018/by Admin

Aravax forms research collaboration with Stanford University

17 November 2017/by Admin

Australian Biotech company launches clinical trials for revolutionary peanut allergy treatment

16 May 2017/by Admin

Aravax forms research collaboration with Benaroya Research Institute

20 January 2017/by Admin

$9 million cash injection for two victorian biotech companies

23 November 2015/by Admin
Page 3 of 3123
© Aravax

Contact Us

Email: info@aravax.com.au

Australia

Level 9, 31 Queen St, Melbourne, Victoria, 3000 Australia
Tel: +61 (0)3 9657 0700

UK

John Eccles House, Oxford Science Park
Oxford, OX4 4GP, United Kingdom

Scroll to top Scroll to top Scroll to top